EWTX Sale Disclosure
Moore John R · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$4.41K
Moore John R General Counsel
EWTX
Transaction date
Aug 12, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 2 days later
EWTX daily price context
Close on/before transaction
$43.56
Aug 12, 2026
Close before public filing
$43.18
Aug 13, 2026
Return since public filing
+2.87%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 99 shares @ $44.5
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001191702-26-000001
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$219.82K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Award | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $106.85K |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $2.62K |
| Edgewise Therapeutics, Inc. EWTX Current | Sale | Aug 12, 2026 | $4.41K |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $105.95K |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Award | Aug 12, 2026 | $0 |